UCD spin-out OxyMem has won the EuropaBio 2016 award for most innovative European biotech SME. The company won the industrial biotech award, and a €10,000 prize, for its breakthrough technology to reduce costs for wastewater treatment.
EuropaBio is the European Association for Bioindustries, and its annual awards, now in their seventh year, recognises innovative European SMEs who have developed novel ways of meeting societal, technical, and environmental problems through the application of biotechnology.
OxyMem, a fast growing Global Cleantech 100 company, is commercialising an innovative infrastructure solution, the Membrane Aerated Biofilm Reactor (MABR), to reduce costs for wastewater treatment. The company’s breakthrough technology tackles energy costs, the industry’s biggest challenge.
Wayne Byrne, CEO, OxyMem, said: “OxyMem is incredibly flattered to receive this Award and to be recognised for our achievements in the biotech space. OxyMem’s technology relies on many scientific disciplines in order to effect the incredible results we have demonstrated. These include; chemical engineering, mechanical engineering, and microbiology to arrive at an operational MABR. Given the breath of markets we serve, food, beverage, agriculture, oil and gas, pharma and the general environmental space it seems logical for us to live under a biotech umbrella from time to time.
“We look forward to our journey with EuropaBio over the coming year and are excited about the engagements we have already established with some of their members.”
OxyMem was co-founded by Prof Eoin Casey, Dr Eoin Syron and Wayne Byrne in 2013 as a spin-out from UCD’s School of Chemical and Bioprocess Engineering. OxyMem currently operates a 25,000sq ft facility and offices in Athlone, Co. Westmeath, to manufacture the OxyMem Membrane Aerated Biofilm Reactor. The company, which also has an office at NovaUCD, employs more than 40 people.
TechCentral Reporters
Subscribers 0
Fans 0
Followers 0
Followers